Financhill
Back

Exelixis 10K Form

Buy
78

EXEL
Exelixis

Last Price:
$36.65
Seasonality Move:
6.23%

7 Day Trial

ALL ACCESS PASS

$ 7

Receive EXEL News And Ratings

See the #1 stock for the next 7 days that we like better than EXEL

EXEL Financial Statistics

Sales & Book Value

Annual Sales: $2.2B
Cash Flow: $226.3M
Price / Cash Flow: 17.12
Annual Sales: $7.97
Price / Book: 4.57

Profitability

EPS (TTM): 1.77000
Net Income (TTM): $521.3M
Gross Margin: $2.1B
Return on Equity: 23.63%
Return on Assets: 18.07%

Exelixis Earnings Forecast

Key Exelixis Financial Ratios

  • The Gross Profit Margin over the past 26 years for EXEL is 96.49%.
  • The Selling, General & Administrative Expenses for EXEL have been equal to 22.69% of Gross Profit Margin.
  • The Research & Development expenses have been 41.98% of Revenue.
  • The Interest Expense is 0.00% of Operating Income.
  • The Net Earning history of EXEL is 24.04% of Total Revenues.
  • Per Share Earnings over the last 27 years have been positive in 17 years.

Exelixis Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: EXEL
CUSIP: 30161Q
Website: exelixis.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 3.63
Quick Ratio: 3.41

Price-to-Earnings

Trailing P/E Ratio: 20.82
Forward P/E Ratio: 12.94

EXEL Technical Analysis vs Fundamental Analysis

Buy
78
Exelixis (EXEL) is a Buy

Is Exelixis a Buy or a Sell?

  • Exelixis stock is rated a Buy
    The current Exelixis [EXEL] share price is $36.65. The Score for EXEL is 78, which is 56% above its historic median score of 50, and infers lower risk than normal.